首页> 美国政府科技报告 >Antifungal Wound Penetration of Amphotericin and Voriconazole in Combat-related Injuries: Case Report.
【24h】

Antifungal Wound Penetration of Amphotericin and Voriconazole in Combat-related Injuries: Case Report.

机译:两性霉素和伏立康唑在战斗相关损伤中的抗真菌创伤渗透:病例报告。

获取原文

摘要

Survivors of combat trauma can have long and challenging recoveries, which may be complicated by infection. Invasive fungal infections are a rare but serious complication with limited treatment options. Currently, aggressive surgical debridement is the standard of care, with antifungal agents used adjunctively with uncertain efficacy. Anecdotal evidence suggests that antifungal agents may be ineffective in the absence of surgical debridement, and studies have yet to correlate antifungal concentrations in plasma and wounds. Here we report the systemic pharmacokinetics a nd wound effluent antifungal concentrations of five wounds from two male patients, aged 28 and 30 yea rs old who sustained combat-related blast injuries in southern Afghanistan, with proven or possible invasive fungal infection. Our data demonstrate that while voriconazole sufficiently penetrated the wound resulting in detectable effluent levels, free amphotericin B (unbound to plasma) was not present in wound effluent despite sufficient concentrations in circulating plasma. In addition, considerable between-patient and within-patient variability was observed in antifungal pharmacokinetic parameters. These data highlight the need for further studies evaluating wound penetration of commonly used antifungals and the role for therapeutic drug monitoring i n providing optimal care for critically ill and injured war fighters.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号